Consequences of increased ROS production during NAFLD include reprogramming of lipid metabolism in the liver, changes in insulin sensitivity, and accumulation of inflammation through interaction with innate immune signals (14). Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.